IDH1 and astrocytoma (excluding glioblastoma): On the other hand, the great majority of WHO grade IV astrocytomas falls into the IDH1-wildtype category (more than 90% of cases) [1], which corresponds most frequently to the clinically defined primary GBM resulting in poor prognosis even with intensive treatments.